Mark Pepin, MD, PhD
@markpepin.bsky.social
Cardiology Fellow and Physician-Scientist @ Stanford Medicine | HFpEF Genomics, Epigenenomics, & Metabolism | Dad x 4
Gendefekt der Maus deckt neues HFpEF-Therapiekonzept auf!
May 31, 2025 at 8:49 PM
Gendefekt der Maus deckt neues HFpEF-Therapiekonzept auf!
“Dog ate my suit,” and a day before @the-asci.bsky.social. Maybe it was time for an upgrade anyway!
April 24, 2025 at 7:00 PM
“Dog ate my suit,” and a day before @the-asci.bsky.social. Maybe it was time for an upgrade anyway!
Going home for the holidays is such a wonderful privilege; here's a glimpse of our first time in years!
January 3, 2025 at 4:30 PM
Going home for the holidays is such a wonderful privilege; here's a glimpse of our first time in years!
That number is not entirely true for HFrecEF, as reported by Hammer et al. (pubmed.ncbi.nlm.nih.gov/37451602/). Considering HFrEF GDMT costs our patients $100/month on average (after insurance). If a 8 week divergence, why not offer trial-of-withdrawal with a 3-month follow-up?
December 1, 2024 at 11:11 PM
That number is not entirely true for HFrecEF, as reported by Hammer et al. (pubmed.ncbi.nlm.nih.gov/37451602/). Considering HFrEF GDMT costs our patients $100/month on average (after insurance). If a 8 week divergence, why not offer trial-of-withdrawal with a 3-month follow-up?
One of these days I'll go... or maybe host my own PepCon.
November 28, 2024 at 9:20 PM
One of these days I'll go... or maybe host my own PepCon.